Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study

✍ Scribed by T. Waddell; S. Gollins; W. Soe; J. Valle; J. Allen; D. Bentley; J. Morris; A. Lloyd; R. Swindell; M. B. Taylor; M. P. Saunders

• Publisher: Springer
• Year: 2010
• Tongue: English
• Weight: 448 KB
• Volume: 67
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-010-1322-0